These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37556325)

  • 1. Entry receptor LDLRAD3 is required for Venezuelan equine encephalitis virus peripheral infection and neurotropism leading to pathogenesis in mice.
    Kafai NM; Janova H; Cain MD; Alippe Y; Muraro S; Sariol A; Elam-Noll M; Klein RS; Diamond MS
    Cell Rep; 2023 Aug; 42(8):112946. PubMed ID: 37556325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus.
    Ma H; Kim AS; Kafai NM; Earnest JT; Shah AP; Case JB; Basore K; Gilliland TC; Sun C; Nelson CA; Thackray LB; Klimstra WB; Fremont DH; Diamond MS
    Nature; 2020 Dec; 588(7837):308-314. PubMed ID: 33208938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3.
    Ma B; Huang C; Ma J; Xiang Y; Zhang X
    Nature; 2021 Oct; 598(7882):677-681. PubMed ID: 34646021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.
    Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE
    J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor.
    Basore K; Ma H; Kafai NM; Mackin S; Kim AS; Nelson CA; Diamond MS; Fremont DH
    Nature; 2021 Oct; 598(7882):672-676. PubMed ID: 34646020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
    Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
    J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-exposure intranasal IFNα suppresses replication and neuroinvasion of Venezuelan Equine Encephalitis virus within olfactory sensory neurons.
    Cain MD; Klein NR; Jiang X; Salimi H; Wu Q; Miller MJ; Klimstra WB; Klein RS
    J Neuroinflammation; 2024 Jan; 21(1):24. PubMed ID: 38233868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.
    Hollidge BS; Cohen CA; Akuoku Frimpong J; Badger CV; Dye JM; Schmaljohn CS
    Virulence; 2021 Dec; 12(1):430-443. PubMed ID: 33487119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry.
    Salimi H; Cain MD; Jiang X; Roth RA; Beatty WL; Sun C; Klimstra WB; Hou J; Klein RS
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Han J; Yang A; Bhomia M; Knollmann-Ritschel B; Puri RK; Maheshwari RK
    BMC Infect Dis; 2017 Apr; 17(1):309. PubMed ID: 28446152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates.
    Smith DR; Schmaljohn CS; Badger C; Ostrowski K; Zeng X; Grimes SD; Rayner JO
    Antiviral Res; 2020 Oct; 182():104875. PubMed ID: 32755661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IKKβ in Venezuelan equine encephalitis virus infection.
    Amaya M; Voss K; Sampey G; Senina S; de la Fuente C; Mueller C; Calvert V; Kehn-Hall K; Carpenter C; Kashanchi F; Bailey C; Mogelsvang S; Petricoin E; Narayanan A
    PLoS One; 2014; 9(2):e86745. PubMed ID: 24586253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in Hypervariable Domain of Venezuelan Equine Encephalitis Virus nsP3 Protein Differentially Affect Viral Replication.
    Meshram CD; Phillips AT; Lukash T; Shiliaev N; Frolova EI; Frolov I
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour Necrosis Factor-α, Chemokines, and Leukocyte Infiltrate Are Biomarkers for Pathology in the Brains of Venezuelan Equine Encephalitis (VEEV)-Infected Mice.
    Phelps AL; Salguero FJ; Hunter L; Stoll AL; Jenner DC; O'Brien LM; Williamson ED; Lever MS; Laws TR
    Viruses; 2023 May; 15(6):. PubMed ID: 37376607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
    Sharma A; Knollmann-Ritschel B
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection.
    Brooke CB; Schäfer A; Matsushima GK; White LJ; Johnston RE
    J Gen Virol; 2012 Apr; 93(Pt 4):797-806. PubMed ID: 22205717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody.
    Brooke CB; Deming DJ; Whitmore AC; White LJ; Johnston RE
    J Virol; 2010 May; 84(9):4556-68. PubMed ID: 20181704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.